BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/11/2024 2:03:42 PM | Browse: 65 | Download: 33
Publication Name World Journal of Gastroenterology
Manuscript ID 91464
Country Poland
2023-12-28 21:28
Peer-Review Started
2023-12-28 21:28
To Make the First Decision
Return for Revision
2024-03-05 21:02
2024-04-07 16:41
Second Decision
2024-04-24 02:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-04-24 05:18
Articles in Press
2024-04-24 05:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-04-29 16:19
Publish the Manuscript Online
2024-05-11 10:58
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration
Manuscript Source Invited Manuscript
All Author List Aleksandra Boldys and Lukasz Buldak
Funding Agency and Grant Number
Corresponding Author Lukasz Buldak, MD, PhD, Associate Professor, Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of Silesia, Medykow 18, Katowice 40-752, Poland. lbuldak@gmail.com
Key Words Metabolic dysfunction-associated steatotic liver disease; Diagnostics; Pathophysiology of metabolic dysfunction-associated steatotic liver disease; Therapy of metabolic dysfunction-associated steatotic liver disease; Therapeutic innovations
Core Tip The transition from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease (MASLD) reflects a broader understanding of liver steatosis beyond obesity-related factors. Early recognition and diagnosis of MASLD are essential. Updated diagnostic protocols and exploration of novel therapeutic avenues focusing on metabolic dysregulation are critical for improving outcomes in MASLD management. Cross-disciplinary collaboration is key to addressing the complexities of this disease effectively.
Publish Date 2024-05-11 10:58
Citation <p>Boldys A, Buldak L. Metabolic dysfunction-associated steatotic liver disease: Navigating terminological evolution, diagnostic frontiers and therapeutic horizon-an editorial exploration. <i>World J Gastroenterol</i> 2024; 30(18): 2387-2390</p>
URL https://www.wjgnet.com/1007-9327/full/v30/i18/2387.htm
DOI https://dx.doi.org/10.3748/wjg.v30.i18.2387
Full Article (PDF) WJG-30-2387-with-cover.pdf
Manuscript File 91464_Auto_Edited-YJP.docx
Answering Reviewers 91464-Answering reviewers.pdf
Audio Core Tip 91464-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 91464-Conflict-of-interest statement.pdf
Copyright License Agreement 91464-Copyright license agreement.pdf
Peer-review Report 91464-Peer-review(s).pdf
Scientific Misconduct Check 91464-Bing-Liu H-2.png
Scientific Editor Work List 91464-Scientific editor work list.pdf